why choose us

Clinical Trials Search

Showing 16,680 of 132,963 result(s)
Increasing PrEP With Trans Women in the Deep South

Status: Completed

Condition: Hiv

Interventions: Ecological momentary assessments to identify and address stressors related to social determinants of health (e.g., housing, substance use, mental heal

Date: 2023-01-06

Oral Fluid Intake After Extubation

Status: COMPLETED

Condition: Intubation

Interventions: The participant will be randomized into two arms.
After the randomization one arm will get the per os fluid intake before the standard time frame

Date: 2023-01-06

Cognitive Reserve-building Activities in Multiple Sclerosis

Status: COMPLETED

Condition: Multiple Sclerosis

Interventions: Participants in the active phase of the study will be asked to increase engagement in certain cognitive leisure activities.
The activities are ch

Date: 2023-01-06

A Study of STAR-0215 in Participants With Hereditary Angioedema

Status: COMPLETED

Condition: Hereditary Angioedema

Interventions: STAR-0215 will be administered as a subcutaneous bolus injection.

Date: 2023-01-06

Efficacy of Hyaluronic Acid Injections on Functional Recovery After Surgery for Prostate Adenoma

Status: COMPLETED

Condition: Prostatic Adenoma

Interventions: 5 injections of Ialuril® Prefill on D0 or D1, D7, D14, D21 and D28 after Holmium laser surgery for prostate adenoma

Date: 2023-01-06

Staying Healthy After Childbirth: My Hypertension Education and Reaching Target Program for Postpartum

Status: COMPLETED

Condition: Hypertension

Interventions: Participants will receive a health coach telehealth;video visit or phone call every 2 weeks for 4 months, for a total of 8 calls.
After thes

Date: 2023-01-05

Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100

Status: COMPLETED

Condition: Bacterial Infections

Interventions: Intravenous infusion

Date: 2023-01-05

Protect the Head to Head Study

Status: Completed

Condition: Embolism

Interventions: Emboliner Embolic Protection Device will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) intervent

Date: 2023-01-05

US Selumetinib Registry

Status: Completed

Condition: Neurofibromatosis Type 1

Interventions:

Date: 2023-01-05